Assessment of brain natriuretic peptide in patients with suspected heart failure: Comparison with radionuclide ventriculography data

Clinica Chimica Acta

Volumn 306, Issue 1-2, 2001, Pages 19-26

  Valli, Nathalie ^a   Georges, Agnès ^a   Corcuff, Jean Benoit ^a   Barat, Jean Louis ^a   Bordenave, Laurence ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Left ventricular dysfunction; Natriuretic peptide B; Radionuclide ventriculography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SINGLE BLIND PROCEDURE;

CARDIAC OUTPUT, LOW; HEART FUNCTION TESTS; HUMANS; NATRIURETIC PEPTIDE, BRAIN; RADIONUCLIDE VENTRICULOGRAPHY;

EID: 0035087471     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00388-6     Document Type: Article

References (50)

1. A natriuretic peptide in porcine brain
2. Validating aminoterminal BNP assays: A word of caution
3. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
4. Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal man
5. Brain natriuretic peptide in an elderly population
6. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical echographic and neurohormonal methods
7. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment
8. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
9. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction
10. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary case
11. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
12. Diagnostic value of B-type natriuretic peptide concentration in patients with acute myocardial infarction
13. Plasma brain natriuretic peptide concentrations predict survival after acute MI
14. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
15. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
16. Natriuretic peptides in assessment of left-ventricular dysfunction
17. Review of ten years of the clinical use of Brain Natriuretic peptide (BNP) in cardiology
18. Medical advances in the treatment of congestive heart failure
19. The prevention of heart failure: A new agenda
20. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
21. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
22. Validity of clinical diagnosis of heart failure in primary health care
23. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy
24. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases
25. Atrial peptides, ANP (1-98) and ANP (99-126) in health and disease in an elderly population
26. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis
27. Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers
28. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
29. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction
30. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction
31. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular dysfunction in elderly patients with cardiovascular disease
32. Biochemical detection of left-ventricular systolic dysfunction
33. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery on cardiac hormonal activation
34. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
35. Plasma concentration of brain natriuretic peptide: Will this new test reduce the need for cardiac investigations?
36. Asymptomatic left ventricular dysfunction in the community
37. Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function
38. Clinical criteria and biochemical markers for the detection of systolic dysfunction
39. BNP: Soon to become a routine measurement in the care of patients with heart failure?
40. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: Cross-sectional study
41. Evaluation of brain natriuretic peptide in the diagnosis of heart failure
42. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population
43. Can heart failure be diagnosed in primary care?
44. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community
45. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure
46. Increased plasma level of BNP in patients with acute myocardial infarction
47. Plasma BNP as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction
48. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
49. Natriuretic system in human heart failure
50. Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide